Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for substance use disorders and related conditions. We’re striving to help people with addiction overcome treatment obstacles and move forward on the path to a healthier life.
Location: United States, California, Oakland
Total raised: $70M
Investors 1
| Date | Name | Website |
| 26.03.2025 | SymBiosis | symbiosis.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.03.2025 | Series B | $70M | - |
Mentions in press and media 4
| Date | Title | Description |
| 25.03.2025 | Tempero Bio's $70 Million Bet on Addiction Treatment: A New Dawn for Substance Use Disorders | In the heart of Oakland, California, a biopharmaceutical company is making waves. Tempero Bio has secured $70 million in Series B financing, a significant leap toward addressing one of America's most pressing health crises: substance use di... |
| 25.03.2025 | Tempero Bio: $70 Million (Series B) Closed To Advance TMP-301 Into Phase 2 Trials For Substance Use Disorders | Tempero Bio – a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders – announced the closing of a $70 million Series B financing. The funding was led by 8VC with participation from Aditum... |
| 24.03.2025 | Tempero Bio Secures $70M Series B Financing | Tempero Bio, an Oakland, CA-based clinical-stage biopharmaceutical company developing treatments for substance use disorders, raised $70M in Series B funding. The round was led by 8VC with participation from Aditum Bio, Khosla Ventures, and... |
| - | Tempero Bio | “Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for substance use disorders and related conditions. We’re striving to help people with addiction overcome treatment obstacles and move forward on the path to a... |